World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
15032
World Ranking
2931
National Ranking
31

Luis Escribano publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luis Escribano sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 164 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Luis Escribano D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luis Escribano sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Luis Escribano is affiliated with the University of Salamanca in Spain. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on several interconnected subfields including Immunology, Physiology, Immunology and Allergy, Pharmacology, and Rheumatology.

The core topics covered in their work include:

  • Mast cells and histamine
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Drug-Induced Adverse Reactions
  • Urticaria and Related Conditions
  • Social Sciences and Policies

Escribano's recent publications demonstrate their engagement with both biomedical and social scientific research. Notable papers include:

  • "Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts", 2020, published in Theranostics
  • "Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features", 2022, published in Clinical and Translational Allergy
  • "Evaluación de la investigación social", 2024, published in Revista Española de Investigaciones Sociológicas

These publications highlight contributions to understanding mast cell biology and clinical features related to mastocytosis, as well as social science investigations relevant to research evaluation.

Frequent co-authors collaborating with Escribano include:

  • Alberto Órfão
  • Peter Valent
  • Cem Akin
  • Karin Hartmann
  • Gunnar Nilsson

Escribano's work is published across a range of journals reflecting both their biomedical and social research interests. Key publication venues include:

  • Theranostics
  • Clinical and Translational Allergy
  • Revista Española de Investigaciones Sociológicas

Best Publications

  • Diagnostic criteria and classification of mastocytosis: a consensus proposal

    Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley

  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

    P. Valent;C. Akin;L. Escribano;M. Födinger

  • Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

    Peter Valent;Cem Akin;Michel Arock;Knut Brockow

  • KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.

    Andres C Garcia-Montero;Maria Jara-Acevedo;Cristina Teodosio;Maria Luz Sanchez

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Karin Hartmann;Luis Escribano;Clive Grattan;Knut Brockow

  • Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

    Luis Escribano;Iván Álvarez-Twose;Laura Sánchez-Muñoz;Andres Garcia-Montero

  • Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

    M. Ocqueteau;A. Orfao;J. Almeida;J. Bladé

  • KIT mutation analysis in mast cell neoplasms : recommendations of the European Competence Network on Mastocytosis

    Michel Arock;Karl Sotlar;Cem Akin;Sigurd Broesby-Olsen

  • Indolent Systemic Mast Cell Disease in Adults: Immunophenotypic Characterization of Bone Marrow Mast Cells and Its Diagnostic Implications

    Luis Escribano;Alberto Orfao;Alberto Orfao;Beatriz Dı́az-Agustin;Beatriz Dı́az-Agustin;Jesús Villarrubia;Jesús Villarrubia

  • Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

    Peter Valent;Cem Akin;Wolfgang R. Sperr;Luis Escribano

  • Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

    Iván Álvarez-Twose;David González de Olano;Laura Sánchez-Muñoz;Almudena Matito

  • Recent advances in the understanding of mastocytosis: the role of KIT mutations*

    Alberto Orfao;Andrés C. Garcia-Montero;Laura Sanchez;Luis Escribano

  • Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

    Peter Valent;Cem Akin;Karin Hartmann;Gunnar Nilsson

  • Mastocytosis: current concepts in diagnosis and treatment.

    L Escribano;C Akin;M Castells;A Orfao

  • Serum Tryptase Levels in Patients with Mastocytosis: Correlation with Mast Cell Burden and Implication for Defining the Category of Disease

    Wolfgang R. Sperr;John-Hendrik Jordan;Michael Fiegl;Luis Escribano

  • Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

    Wolfgang R Sperr;Luis Escribano;John-Hendrik Jordan;Gerit-Holger Schernthaner

  • One-Step Detection of c-kit Point Mutations Using Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping and Hybridization Probes

    Karl Sotlar;Luis Escribano;Olfert Landt;Stefanie Möhrle

  • Immunophenotypic analysis of Waldenstrom's macroglobulinemia

    J.F. San Miguel;M.B. Vidriales;E. Ocio;G. Mateo

  • Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

    Mariana Castells;Dean D. Metcalfe;Luis Escribano

  • Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis

    I. Alvarez-Twose;S. Vañó-Galván;L. Sánchez-Muñoz;J. M. Morgado

  • Expression of the c-kit (CD117) Molecule in Normal and Malignant Hematopoiesis

    L Escribano;M Ocqueteau;J Almeida;A Orfao

  • Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

    M P Purdue;Q Lan;T J Kemp;A Hildesheim

Frequent Co-Authors

Alberto Orfao
Alberto Orfao University of Salamanca
Peter Valent
Peter Valent Medical University of Vienna
Cem Akin
Cem Akin University of Michigan–Ann Arbor
Lawrence B. Schwartz
Lawrence B. Schwartz Virginia Commonwealth University
Dean D. Metcalfe
Dean D. Metcalfe National Institute of Allergy and Infectious Diseases
Julia Almeida
Julia Almeida University of Salamanca
Karin Hartmann
Karin Hartmann University Hospital of Basel
Massimo Triggiani
Massimo Triggiani University of Salerno
Knut Brockow
Knut Brockow Technical University of Munich
Mariana Castells
Mariana Castells Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career pathways. Many professionals transition into specialized roles by enrolling in programs like acute care certification for fnp, which prepares family nurse practitioners for critical patient care environments.

Accelerated programs offer a fast track for those looking to advance quickly in nursing. Options such as an accelerated nurse practitioner program provide flexible online study with rigorous training, ideal for building specialized knowledge in immune-related healthcare.

For individuals without a nursing background, enrolling in online rn programs for non nurses in florida can be a vital step toward entering the healthcare field, enabling them to gain foundational skills before focusing on immunology-related roles.

Additionally, exploring accelerated nursing programs can simplify the pathway into nursing, providing an expedited route to earning a Bachelor of Science in Nursing (BSN) and eventually specializing in immunology or related fields.

Best Scientists Citing Luis Escribano

Trending Scientists

Recently Published Articles